Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents	$ 446,976	$ 88,415
Other receivable	2,879	2,880
Other assets	159,101	52,686
Total current assets	608,956	143,981
Long-term assets
Long-term receivable	582,377	582,377
Property and equipment - net	28,017	36,568
Deferred compensation	1,666,667	2,083,334
Total long-term assets	2,277,061	2,702,279
TOTAL ASSETS	2,886,017	2,846,260
Current liabilities
Accounts payable	422,015	472,868
Accrued officer compensation	206,000	206,000
Notes payable including accrued interest of $233,541 at June 30, 2020 and $119,218 at December 31, 2019	3,956,972	3,467,890
Due to related parties	50,000	50,000
Accrued expenses	55,526	23,588
Accrued dividends	48,079	48,079
Deferred revenues	66,368
Total current liabilities	4,804,960	4,268,425
Long-term liabilities
Long-term notes payable	1,132,760	1,500,000
Total liabilities	5,937,720	5,768,425
Commitments and contingencies
Stockholders' (deficit)
Series A Convertible Preferred Stock, $.001 par value, 2,000,000 shares authorized; 13,602 shares issued and outstanding at June 30, 2020 and at December 31, 2019	14	14
Common stock, $.001 par value, 500,000,000 shares authorized; 212,143,146 and 206,569,063 shares issued and outstanding at June 30, 2020 and at December 31, 2019, respectively	212,143	206,569
Additional paid-in capital	88,412,212	85,907,523
Accumulated deficit	(91,676,072)	(89,036,271)
Total stockholders' (deficit)	(3,051,703)	(2,922,165)
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT)	$ 2,886,017	$ 2,846,260